Genetic analysis of H3N2 influenza A viruses isolated in 2006-2007 in Nairobi, Kenya

Influenza and other Respiratory Viruses

Volumn 2, Issue 3, 2008, Pages 107-113

  Bulimo, Wallace D ^a   Garner, Jason L ^b   Schnabel, David C ^a   Bedno, Sheryl A ^c   Njenga, M Kariuki ^d   Ochieng, Walter O ^a   Maldonado, Jaime ^a   Amukoye, Evans ^a   Magana, James M ^a   Simwa, James M ^a   Ofula, Victor O ^a   Lifumo, Samwel M ^a   Wangui, Julia ^a   Breiman, Robert F ^d   Martin, Samuel K ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b USAF   (United States)

^c Walter Reed Army Medical Center   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Genetic variant; H3N2; Influenza A; Kenya

Indexed keywords

EPITOPE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIBODY COMBINING SITE; ANTIBODY TITER; ANTIGENIC VARIATION; ARTICLE; CHILD; CONFORMATIONAL TRANSITION; DISEASE SURVEILLANCE; FEMALE; GENETIC VARIABILITY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN TISSUE; INFANT; INFLUENZA VIRUS A H3N2; KENYA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPE; VIRAL GENETICS; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS MUTATION; VIRUS STRAIN;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFANT; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; KENYA; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; YOUNG ADULT;

EID: 64949170972     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2008.00044.x     Document Type: Article

References (24)

1. Hilleman MR. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 2002; 20:3068-3087.
2. Stohr K. Overview of the WHO Global Influenza Programme. Dev Biol (Basel) 2003; 115:3-8.
3. Stohr K. The WHO Global Influenza Program and its animal influenza network. Avian Dis 2003; 47:934-938.
4. CDC. Isolation of avian influenza A (H5N1) viruses from humans - Hong Kong, May-December. MMWR Morb Mortal Wkly Rep 1997; 46:1204-1207.
5. Subbarao K, Klimov A, Katz J et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998; 279:393-396.
6. de Jong JC, Claas EC, Osterhaus AD. Influenza A (H5N1) in Hong Kong: forerunner of a pandemic or just a scientifically interesting phenomenon and a useful exercise in pandemiology? Ned Tijdschr Geneeskd 1998; 142:1252-1256.
7. Claas EC, Osterhaus AD, van Beek R et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998; 351:472-477.
8. Stohr K. The global agenda on influenza surveillance and control. Vaccine 2003; 21:1744-1748.
9. Fauci AS. Pandemic influenza threat and preparedness. Emerg Infect Dis 2006; 12:73-77.
10. Kendal AP, Pereira MS, Skehel JJ. Concepts and Procedures for Laboratory-based Influenza Surveillance. Atlanta, GA: Centers for Disease Control and Prevention, 1982.
11. Yamada A, Imanishi J, Nakajima E, Nakajima K, Nakajima S. Detection of influenza viruses in throat swab by using polymerase chain reaction. Microbiol Immunol 1991; 35:259-265.
12. Zhang WD, Evans DH. Detection and identification of human influenza viruses by the polymerase chain reaction. J Virol Methods 1991; 33:165-189.
13. Hall TA. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999; 41:95-98.
14. Edgar RC. MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004; 32:1792- 1797.
15. Kumar S, Tamura K, Nei M. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004; 5:150-163.
16. Kopp J, Schwede T. The SWISS-MODEL repository of annotated three-dimensional protein structure homology models. Nucleic Acids Res 2004; 32:D230-D234.
17. Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 2003; 31:3381-3385.
18. Bernstein HJ. Recent changes to RasMol, recombining the variants. Trends Biochem Sci 2000; 25:453-455.
19. Sayle RA, Milner-White EJ. RASMOL: Biomolecular graphics for all. Trends Biochem Sci 1995; 20:374.
20. Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 1998; 95:409-417.
21. Wiley DC, Skehel JJ. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 1987; 56:365-394.
22. Hughey PG, Roberts PC, Holsinger LJ, Zebedee SL, Lamb RA, Compans RW. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology 1995; 212:411-421.
23. Webster RG, Brown LE, Laver WG. Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies. Virology 1984; 135:30-42.
24. Zebedee SL, Lamb RA. Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 1988; 62:2762-2772.